These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8410683)
1. Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal. Xu X; Selick P; Pang KS J Pharmacokinet Biopharm; 1993 Feb; 21(1):43-74. PubMed ID: 8410683 [TBL] [Abstract][Full Text] [Related]
2. Hepatic modeling of metabolite kinetics in sequential and parallel pathways: salicylamide and gentisamide metabolism in perfused rat liver. Xu X; Pang KS J Pharmacokinet Biopharm; 1989 Dec; 17(6):645-71. PubMed ID: 2635738 [TBL] [Abstract][Full Text] [Related]
3. Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugates in single-pass in situ perfused rat liver. Xu X; Tang BK; Pang KS J Pharmacol Exp Ther; 1990 Jun; 253(3):965-73. PubMed ID: 2359032 [TBL] [Abstract][Full Text] [Related]
4. Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity. Morris ME; Pang KS J Pharmacokinet Biopharm; 1987 Oct; 15(5):473-96. PubMed ID: 3694493 [TBL] [Abstract][Full Text] [Related]
5. Sequestered endoplasmic reticulum space for sequential metabolism of salicylamide. Coupling of hydroxylation and glucuronidation. Tirona RG; Pang KS Drug Metab Dispos; 1996 Aug; 24(8):821-33. PubMed ID: 8869815 [TBL] [Abstract][Full Text] [Related]
6. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study. Pang KS; Barker F; Schwab AJ; Goresky CA J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326 [TBL] [Abstract][Full Text] [Related]
7. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation. Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ; Stillwell RN J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487 [TBL] [Abstract][Full Text] [Related]
8. Competing pathways in drug metabolism. II. An identical, anterior enzymic distribution for 2- and 5-sulfoconjugation and a posterior localization for 5-glucuronidation of gentisamide in the rat liver. Morris ME; Yuen V; Pang KS J Pharmacokinet Biopharm; 1988 Dec; 16(6):633-56. PubMed ID: 3251033 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of acetaminophen sulfation by 2,6-dichloro-4-nitrophenol in the perfused rat liver preparation. Lack of a compensatory increase of glucuronidation. Fayz S; Cherry WF; Dawson JR; Mulder GJ; Pang KS Drug Metab Dispos; 1984; 12(3):323-9. PubMed ID: 6145559 [TBL] [Abstract][Full Text] [Related]
10. Hepatic conjugation/deconjugation cycling pathways. Computer simulations examining the effect of Michaelis-Menten parameters, enzyme distribution patterns, and a diffusional barrier on metabolite disposition. Hansel SB; Morris ME J Pharmacokinet Biopharm; 1996 Apr; 24(2):219-43. PubMed ID: 8875348 [TBL] [Abstract][Full Text] [Related]
11. An understanding of flow- and diffusion-limited vs. carrier-mediated hepatic transport: a simulation study. Geng WP; Poon K; Pang KS J Pharmacokinet Biopharm; 1995 Aug; 23(4):347-78. PubMed ID: 8882745 [TBL] [Abstract][Full Text] [Related]
12. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver. Chiba M; Schwab AJ; Goresky CA; Pang KS Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929 [TBL] [Abstract][Full Text] [Related]
13. Membrane transport in hepatic clearance of drugs. II: Zonal distribution patterns of concentration-dependent transport and elimination processes. Kwon Y; Morris ME Pharm Res; 1997 Jun; 14(6):780-5. PubMed ID: 9210197 [TBL] [Abstract][Full Text] [Related]
14. First-pass metabolism of salicylamide. Studies in the once-through vascularly perfused rat intestine-liver preparation. Xu X; Hirayama H; Pang KS Drug Metab Dispos; 1989; 17(5):556-63. PubMed ID: 2573500 [TBL] [Abstract][Full Text] [Related]
15. Sulfoconjugation and glucuronidation of salicylamide in isolated rat hepatocytes. Koike M; Sugeno K; Hirata M J Pharm Sci; 1981 Mar; 70(3):308-11. PubMed ID: 7264898 [TBL] [Abstract][Full Text] [Related]
16. Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation. Morris ME; Yuen V; Tang BK; Pang KS J Pharmacol Exp Ther; 1988 May; 245(2):614-24. PubMed ID: 3367309 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of sulfate conjugation in the rat: pharmacokinetics and characterization of the inhibitory effect of 2,6-dichloro-4-nitrophenol. Koster H; Halsema I; Scholtens E; Meerman JH; Pang KS; Mulder GJ Biochem Pharmacol; 1982 May; 31(10):1919-24. PubMed ID: 7104024 [TBL] [Abstract][Full Text] [Related]
18. Conjugation of salicylamide in the intestinal wall of dogs and rabbits. Podder SK; Nakashima M; Nakamura T; Sasaki H; Nakamura J; Shibasaki J J Pharmacobiodyn; 1986 Nov; 9(11):917-22. PubMed ID: 3559882 [TBL] [Abstract][Full Text] [Related]
19. Carrier-mediated uptake and excretion of bromosulfophthalein-glutathione in perfused rat liver: a multiple indicator dilution study. Geng WP; Schwab AJ; Goresky CA; Pang KS Hepatology; 1995 Oct; 22(4 Pt 1):1188-207. PubMed ID: 7557871 [TBL] [Abstract][Full Text] [Related]
20. Kinetics of sulfation and glucuronidation of harmol in the perfused rat liver preparation. Disappearance of aberrances in glucuronidation kinetics by inhibition of sulfation. Koster H; Halsema I; Scholtens E; Pang KS; Mulder GJ Biochem Pharmacol; 1982 Oct; 31(19):3023-8. PubMed ID: 7150332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]